By Business/Source
Currency:CNY
2025/FY
2025/FY
2025/H1
2024/FY
2024/H1
2023/FY
2023/H1
2022/FY
2022/H1
2021/FY
2021/H1
2020/FY
2020/H1
2019/FY
2019/H1
2018/FY
2018/H1
2017/FY
2017/H1
2016/FY
2016/H1
2015/FY
2015/H1
2014/FY
2014/H1
2013/FY
2013/H1
2012/FY
2012/H1
2011/FY
2011/H1
2010/FY
2010/H1
2009/FY
2007/FY
2007/H1
2006/FY
Stock NameRevenueRatio
一方4.91B33.31%
环球4.54B30.80%
天江3.2B21.68%
同济堂2.1B14.22%
By Product
Currency:CNY
2025/FY
2025/FY
2025/H1
2024/FY
2024/H1
2023/FY
2023/H1
2022/FY
2022/H1
2021/FY
2021/H1
2020/FY
2020/H1
2019/FY
2019/H1
2018/FY
2018/H1
2017/FY
2017/H1
2016/FY
2016/H1
2015/FY
2015/H1
2014/FY
2014/H1
2013/FY
2013/H1
2012/FY
2012/H1
2011/FY
2011/H1
2010/FY
2010/H1
2009/FY
2007/FY
2007/H1
2006/FY
Stock NameRevenueRatio
Traditional Chinese medicine formula granules6.1B41.36%
Chinese patent medicine4.25B28.81%
Traditional Chinese medicine slice3.33B22.61%
中药材生产及经营829.72M5.63%
中医药大健康234.55M1.59%
By Country/Region
Currency:CNY
2025/FY
2025/FY
2025/H1
2024/FY
2024/H1
2023/FY
2023/H1
2022/FY
2022/H1
2021/FY
2021/H1
2020/FY
2020/H1
2019/FY
2019/H1
2018/FY
2015/FY
2014/FY
2013/FY
2012/FY
Stock NameRevenueRatio
The mainland of China14.58B98.86%
海外及其他地方91.8M0.62%
Hong Kong, China76.29M0.52%
